The cell and gene supply chain is a complex and rapidly evolving ecosystem that supports the development and manufacturing of cellular therapies, gene therapies, and other biologics. It involves a network of stakeholders, including biobanks, cell manufacturers, contract research organizations, and contract manufacturing organizations, who work together to collect, process, store, and distribute biological materials, such as cells, tissues, and genes. The supply chain is critical to ensuring the quality, safety, and efficacy of these innovative therapies, and its integrity is crucial to building trust with patients and regulatory authorities.